Table 3.

Serum miRNAs correlating with baseline clinical parameters.

	miRNA	Correlation coefficient	p-value
ALSFRS-R	hsa-miR-32-5p	0.468	0.043
	hsa-miR-127-3p	−0.463	0.046
	hsa-miR-191-5p	−0.579	0.01
	hsa-miR-770-5p	−0.482	0.036
VC	hsa-miR-101-3p	0.606	0.006
	hsa-miR-15b-3p	0.528	0.020
	hsa-miR-19a-3p	0.635	0.003
	hsa-miR-361-3p	0.518	0.023
	hsa-miR-451a	0.622	0.004
	hsa-miR-92a-1-5p	0.494	0.032
	hsa-miR-1	−0.510	0.026
	hsa-miR-133a-3p	−0.729	0.0004
	hsa-miR-133b	−0.620	0.005
	hsa-miR-182-3p	−0.514	0.024
	hsa-miR-221-3p	−0.605	0.006
	hsa-miR-330-3p	−0.475	0.04
	hsa-miR-584-5p	−0.575	0.010
	hsa-miR-589-3p	−0.492	0.033
Disease duration	hsa-miR-9-3p	0.455	0.044
	hsa-miR-142-3p	−0.558	0.012
	hsa-miR-21-5p	−0.457	0.044
	hsa-miR-33a-5p	−0.450	0.048
	hsa-miR-34a-5p	−0.535	0.016
	hsa-miR-376b-3p	−0.464	0.039
	hsa-miR-491-5p	−0.473	0.035

ALSFRS-R = revised ALS Functional rating scale, VC = vital capacity